Utilizing gold-standard PCR technology for sensitive detection of viral pathogens and genetic markers. This facility is essential for early diagnosis and management of hereditary conditions not identifiable through traditional laboratory methods.
PCR technology is significantly more sensitive; it can detect viral genetic material at much lower levels, catching infections that a rapid test might miss during the early or late stages.
Yes; by identifying specific genetic markers (such as BRCA), molecular biology can provide a roadmap for preventative screenings and personalized risk management.
This test measures the exact number of viral particles in the blood; a decreasing viral load confirms that the antiviral medication is working effectively.
Yes; GeneXpert and other molecular methods provide a rapid and highly accurate diagnosis of TB and can even detect if the strain is resistant to standard medications.
Antibody tests tell you if you were infected in the past; DNA/RNA tests confirm if the virus is currently active in your system.
Utilized for the early detection of viral loads, screening for hereditary health risks, or when traditional testing methods cannot identify specific genetic markers.